NO20072433L - Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel - Google Patents
Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddelInfo
- Publication number
- NO20072433L NO20072433L NO20072433A NO20072433A NO20072433L NO 20072433 L NO20072433 L NO 20072433L NO 20072433 A NO20072433 A NO 20072433A NO 20072433 A NO20072433 A NO 20072433A NO 20072433 L NO20072433 L NO 20072433L
- Authority
- NO
- Norway
- Prior art keywords
- mequitazine
- cyclodextrin
- complex consisting
- complex
- interaction agent
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0411202A FR2876910B1 (fr) | 2004-10-21 | 2004-10-21 | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
| PCT/EP2005/055388 WO2006042857A2 (fr) | 2004-10-21 | 2005-10-19 | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072433L true NO20072433L (no) | 2007-05-11 |
Family
ID=34949969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072433A NO20072433L (no) | 2004-10-21 | 2007-05-11 | Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7749982B2 (pt) |
| EP (1) | EP1802348A2 (pt) |
| JP (1) | JP5157447B2 (pt) |
| KR (1) | KR101273840B1 (pt) |
| CN (1) | CN101043908B (pt) |
| AR (1) | AR051593A1 (pt) |
| AU (1) | AU2005296875B2 (pt) |
| BR (1) | BRPI0516233A (pt) |
| CA (1) | CA2583783C (pt) |
| FR (1) | FR2876910B1 (pt) |
| IL (1) | IL182412A (pt) |
| MX (1) | MX2007004787A (pt) |
| NO (1) | NO20072433L (pt) |
| NZ (1) | NZ555238A (pt) |
| RU (1) | RU2389491C2 (pt) |
| TW (1) | TWI372759B (pt) |
| WO (1) | WO2006042857A2 (pt) |
| ZA (1) | ZA200703080B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2914187B1 (fr) * | 2007-03-28 | 2011-01-21 | Pf Medicament | Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique. |
| JP7029886B2 (ja) * | 2017-04-28 | 2022-03-04 | ロート製薬株式会社 | 医薬組成物及びその製造方法 |
| KR20220085094A (ko) | 2020-12-14 | 2022-06-22 | 메디케어제약 주식회사 | 알레르기성 결막염을 동반한 만성 비염을 치료하는 약제학적 복합제제 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1250534A (pt) | 1969-03-03 | 1971-10-20 | ||
| FR2522660A1 (fr) * | 1982-03-05 | 1983-09-09 | Pharmuka Lab | Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant |
| IT1196033B (it) | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| US4975426A (en) * | 1987-06-08 | 1990-12-04 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| JP2735122B2 (ja) * | 1988-06-13 | 1998-04-02 | 旭化成工業株式会社 | メキタジンの液状シロップ製剤 |
| FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
| KR920006911B1 (ko) * | 1989-06-14 | 1992-08-22 | 신풍제약 주식회사 | 안정한 피록시캄 주사액 조성물 및 그의 제조방법 |
| TW262497B (en) * | 1994-06-29 | 1995-11-11 | Toshiba Co Ltd | Washing machine |
| FR2742053B1 (fr) | 1995-12-06 | 1998-03-06 | Chauvin Lab Sa | Compositions pharmaceutiques a base de mequitazine |
| CN1230123A (zh) * | 1996-07-11 | 1999-09-29 | 荷兰发马克有限公司 | 含碱性药物的酸加成盐的药物组合物 |
| JPH10167954A (ja) * | 1996-12-05 | 1998-06-23 | Takada Seiyaku Kk | メキタジン製剤 |
| GB9800936D0 (en) * | 1997-05-10 | 1998-03-11 | Univ Nottingham | Biofunctional polymers |
| EP1018340B1 (en) * | 1999-01-06 | 2003-09-10 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them |
| FR2788436A1 (fr) * | 1999-01-14 | 2000-07-21 | Pf Medicament | Composition d'un derive de phenothiazine |
| FR2815540B1 (fr) * | 2000-10-19 | 2005-06-10 | Separex Sa | Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote |
| WO2002089851A1 (fr) * | 2001-03-06 | 2002-11-14 | Separex (Societe Anonyme) | Procede de fabrication de complexes hote-client |
| FR2830761B1 (fr) | 2001-10-12 | 2003-12-12 | Pf Medicament | Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique |
| FR2830760B1 (fr) * | 2001-10-12 | 2004-06-04 | Pf Medicament | Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique |
| FR2854079B1 (fr) * | 2003-04-25 | 2007-11-30 | Pf Medicament | Procede de preparation de complexes moleculaires |
| SI2260871T1 (sl) * | 2004-04-01 | 2013-09-30 | Pierre Fabre Medicament | Kompleksi sestavin, ki vključujejo piroksikam, ciklodekstrin in arginin |
-
2004
- 2004-10-21 FR FR0411202A patent/FR2876910B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-19 AU AU2005296875A patent/AU2005296875B2/en not_active Ceased
- 2005-10-19 EP EP05801647A patent/EP1802348A2/fr not_active Withdrawn
- 2005-10-19 RU RU2007118640/15A patent/RU2389491C2/ru not_active IP Right Cessation
- 2005-10-19 CN CN2005800358701A patent/CN101043908B/zh not_active Expired - Fee Related
- 2005-10-19 NZ NZ555238A patent/NZ555238A/en not_active IP Right Cessation
- 2005-10-19 JP JP2007537271A patent/JP5157447B2/ja not_active Expired - Fee Related
- 2005-10-19 US US11/665,839 patent/US7749982B2/en not_active Expired - Fee Related
- 2005-10-19 MX MX2007004787A patent/MX2007004787A/es active IP Right Grant
- 2005-10-19 CA CA2583783A patent/CA2583783C/fr not_active Expired - Fee Related
- 2005-10-19 KR KR1020077010998A patent/KR101273840B1/ko active IP Right Grant
- 2005-10-19 WO PCT/EP2005/055388 patent/WO2006042857A2/fr active Application Filing
- 2005-10-19 BR BRPI0516233-5A patent/BRPI0516233A/pt not_active IP Right Cessation
- 2005-10-20 TW TW094136627A patent/TWI372759B/zh not_active IP Right Cessation
- 2005-10-21 AR ARP050104407A patent/AR051593A1/es unknown
-
2007
- 2007-04-10 IL IL182412A patent/IL182412A/en not_active IP Right Cessation
- 2007-04-16 ZA ZA200703080A patent/ZA200703080B/en unknown
- 2007-05-11 NO NO20072433A patent/NO20072433L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1802348A2 (fr) | 2007-07-04 |
| MX2007004787A (es) | 2007-05-15 |
| CA2583783A1 (fr) | 2006-04-27 |
| US7749982B2 (en) | 2010-07-06 |
| JP5157447B2 (ja) | 2013-03-06 |
| CN101043908A (zh) | 2007-09-26 |
| KR101273840B1 (ko) | 2013-06-11 |
| WO2006042857A3 (fr) | 2006-07-27 |
| CN101043908B (zh) | 2011-11-16 |
| AU2005296875B2 (en) | 2011-03-31 |
| CA2583783C (fr) | 2013-05-21 |
| TW200621770A (en) | 2006-07-01 |
| FR2876910B1 (fr) | 2007-04-13 |
| IL182412A (en) | 2015-02-26 |
| RU2389491C2 (ru) | 2010-05-20 |
| AR051593A1 (es) | 2007-01-24 |
| JP2008517035A (ja) | 2008-05-22 |
| AU2005296875A1 (en) | 2006-04-27 |
| FR2876910A1 (fr) | 2006-04-28 |
| WO2006042857A2 (fr) | 2006-04-27 |
| TWI372759B (en) | 2012-09-21 |
| ZA200703080B (en) | 2008-05-28 |
| NZ555238A (en) | 2010-04-30 |
| KR20070084223A (ko) | 2007-08-24 |
| RU2007118640A (ru) | 2008-11-27 |
| IL182412A0 (en) | 2007-07-24 |
| BRPI0516233A (pt) | 2008-08-26 |
| US20070293454A1 (en) | 2007-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080633L (no) | Bis(tio-hydrazidamid)formulering | |
| NO20091609L (no) | Process for producing iron arsenide compound with good crystallinity | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| HRP20030071B1 (hr) | Postupci za lijeäśenje reumatskih bolesti uporabom topljivih ctla4 mutantnih molekula | |
| NO20073753L (no) | En sammensetning og fremgangsmate for fremstilling av et proppemiddel | |
| NO20054957L (no) | Subtituerte karboksylsyrer | |
| MXPA06012500A (es) | Compuestos para el tratamiento de la enfermedad de alzheimer y para la inhibicion de la produccion del peptido beta-amiloideo. | |
| RS20080533A (en) | Triazolopyrazine derivatives useful as anticancer agents | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| WO2003027094A3 (en) | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | |
| NO20064676L (no) | Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre | |
| NO20072066L (no) | Cyklodekstrininnlemmelseskomplekser og fremgangsmater ved fremstilling derav | |
| EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
| TW200718424A (en) | Novel compounds of amino sulfonyl derivatives | |
| MXPA05011150A (es) | 2-hidroxi-3-diaminoalcanos de benzamida. | |
| TW200505418A (en) | Phenacyl 2-hydroxy-3-diaminoalkanes | |
| RU2013132210A (ru) | Новая фармацевтическая композиция, включающая нпвс и циклодекстрин | |
| WO2006125181A3 (en) | Piperidine derivatives and their use as stearoyl-coa desaturase modulators | |
| MY136686A (en) | Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| NO341574B1 (no) | Forbindelse, farmasøytisk sammensetning og sett for behandling av cancer eller i en avbildningsmetode. | |
| MA31567B1 (fr) | Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique | |
| ATE404211T1 (de) | Xenon als nmda-antogonist zur neuroprotektion | |
| NO20072433L (no) | Kompleks som bestar av mekitazin, et syklodekstrin og et interaksjonsmiddel | |
| DE602007001463D1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |